China Synergy Fund, the dual currency investment vehicle established earlier this year by TPG Capital and CICC Capital, has agreed to acquire Electropoli, a provider of surface treatment services, from French automotive conglomerate Impala Group.
Trail Capital, a Paris-based private equity firm, also participated in the transaction, according to a release. Financial details have not been disclosed. China Synergy will help Electropoli expand into...
China-based data storage software services provider XSKY has raised a RMB320 million ($45 million) Series D led by China's State Owned Capital Venture Capital Fund.
CF PharmTech, a Chinese medical devices maker focused on innovative respiratory products, has raised a $50 million Series F round with support from CICC Capital.
Chinese insulin manufacturer Gan & Lee Pharmaceuticals, which counts Qiming Venture Partners and Goldman Sachs among its investors, raised RMB2.5 billion ($354 million) through an A-share IPO.
KKR has agreed to buy a 54% stake in Indian drug maker J.B. Chemicals & Pharmaceuticals for INR31.1 billion ($416 million) and made an open offer for an additional 26% of the company.